Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDuman, Nilay
dc.contributor.authorDuman, Reşat
dc.contributor.authorVurmaz, Ayhan
dc.date.accessioned2023-05-05T14:05:18Z
dc.date.available2023-05-05T14:05:18Z
dc.date.issued2022en_US
dc.identifier.citationDuman, N., Duman, R., & Vurmaz, A. (2023). Effects of second-generation H1-antihistamine drugs on angiogenesis in in vivo chick chorioallantoic membrane model. Cutaneous and Ocular Toxicology, 42(1), 8-11.en_US
dc.identifier.issn1556-9535
dc.identifier.urihttps://dx.doi.org/10.1080/15569527.2022.2152040.
dc.identifier.urihttps://hdl.handle.net/20.500.12933/1511
dc.description.abstractBackground: Literature on the effects of second-generation H1-antihistamines on angiogenesis is limited. Objectives: To investigate the effects of cetirizine, desloratadine, and rupatadine (second-generation H1-antihistamines commonly used in dermatology clinics) on angiogenesis in an in vivo chick chorioallantoic membrane (CAM) model. Methods: The study was approved by the local ethics committee on animal experimentation. Forty fertilized specific pathogen free eggs were incubated and kept under appropriate temperature and humidity control. Drug solutions were prepared in identical concentrations by dissolving powders in phosphate-buffered saline (PBS). On the third day of the incubation, a small window was opened on the CAM and 0.1 mL desloratadine (1.5 μg/0.1 mL) in the first group, 0.1 mL cetirizine (1.5 μg/0.1 mL) in the second group, 0.1 mL rupatadine in the third group (1.5 μg/0.1 mL), and PBS (0.1 mL) in the fourth group were administered by injection. On the eighth day of incubation, the vascular structures of the CAMs were macroscopically examined and standard digital photographs were taken. The digital images were analyzed and data including mean vessel density, thickness, and number were compared between groups. p < 0.05 was considered statistically significant. Results: Vessel densities were similar in the desloratadine, cetirizine, and control groups, whereas they were significantly less in the rupatadine group (p = 0.01). Furthermore, the rupatadine group had significantly lower vessel thickness and number compared with the other groups (p < 0.05 for both). Conclusions: Rupatadine showed anti-angiogenic effects in the chick CAM model, compared with desloratadine and cetirizine. The anti-angiogenic effect of rupatadine could be due to its platelet-activating factor (PAF) receptor inhibition. Thus, rupatadine could be a treatment agent in pathological processes in which angiogenesis is responsible. Further studies with larger series are needed to clarify this potential.en_US
dc.language.isoengen_US
dc.publisherInforma Healthcareen_US
dc.relation.isversionof10.1080/15569527.2022.2152040.en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectSecond-Generation H1-Antihistaminesen_US
dc.subjectAngiogenesisen_US
dc.subjectCetirizineen_US
dc.subjectDesloratadineen_US
dc.subjectin Vivo Chick Chorioallantoic Membrane Modelen_US
dc.subjectRupatadineen_US
dc.titleEffects of second-generation H1-antihistamine drugs on angiogenesis in in vivo chick chorioallantoic membrane modelen_US
dc.typearticleen_US
dc.authorid0000-0002-1840-2900en_US
dc.departmentAFSÜen_US
dc.contributor.institutionauthorVurmaz, Ayhan
dc.identifier.volume42en_US
dc.identifier.issue1en_US
dc.identifier.startpage8en_US
dc.identifier.endpage11en_US
dc.relation.journalCutaneous and Ocular Toxicologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster